Results 171 to 180 of about 166,786,075 (302)
Improving the Hosmer-Lemeshow goodness-of-fit test in large models with replicated Bernoulli trials. [PDF]
Surjanovic N, Loughin TM.
europepmc +1 more source
Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark. [PDF]
Sun Y, Li M, Gilbert PB.
europepmc +1 more source
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand +5 more
wiley +1 more source
The graphical method for goodness of fit test in the inverse Weibull distribution based on multiply type-II censored samples. [PDF]
Kang SB, Han JT.
europepmc +1 more source
ABSTRACT Objective Early risk stratification may support clinical decision‐making in spontaneous intracerebral hemorrhage (ICH). We aimed to develop and internally validate HAGIV, a score integrating frequency of imaging markers (FIM), a time‐adjusted non‐contrast computed tomography (CT) metric of hematoma expansion, with established predictors for 90‐
Lei Song +10 more
wiley +1 more source
Pearson-type goodness-of-fit test with bootstrap maximum likelihood estimation. [PDF]
Yin G, Ma Y.
europepmc +1 more source
Limited Information Goodness-Of-Fit Testing In Multidimensional Contingency Tables [PDF]
We introduce a family of goodness-of-fit statistics for testing composite null hypotheses in multidimensional contingency tables of arbitrary dimensions. These statistics are quadratic forms in marginal residuals up to order r.
ALBERTO MAYDEU
core
Bi‐ and Mono‐Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy
ABSTRACT Objective RFC1 biallelic repeat expansion is increasingly recognized as a cause of chronic idiopathic axonal polyneuropathy (CIAP), but it remains challenging to know who to test. This study aims to determine the prevalence of biallelic and monoallelic RFC1 expansions and their corresponding neuropathy phenotypes in CIAP patients and identify ...
Amro M. Stino +25 more
wiley +1 more source
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source

